Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced that its Board of Directors has approved a $250 million share repurchase authorization ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE